Corrections Issued for Nature Articles on Cancer Research and Epigenetics
NEW YORK, NY - February 6, 2026 - Several corrections have been issued for articles published in Nature, addressing errors in figures and data presentation related to cancer research and epigenetic detection. These corrections, impacting articles published in 2022 and 2024, highlight the ongoing scrutiny and refinement within scientific publishing.
One correction, detailed in a Nature article originally published on November 6, 2024, focuses on a study concerning colibactin-driven colon cancer. According to the correction notice, several labels in Figures 2 and 3 were inaccurate. The changes involved correcting labels such as "ΔfimH" to "ΔfmlH" and "fmlH" to "fimH" in the figures. The corrected versions have been updated in both the HTML and PDF versions of the article, as reported by Nature News.
Another correction, also from Nature, addresses inaccuracies in the Extended Data of a manuscript published on May 18, 2022. This article focused on how PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. The errors were found during the assembly of the Extended Data Figure panels, although the raw data in the Supplementary Information remained accurate. The authors refined the labeling of uncut western blots provided in the Supplementary Information to ensure clarity.
In related scientific developments, researchers from the Institute of Science, Tokyo, have developed a light-sensitive probe for detecting epigenetic intermediates. This probe crosslinks with 5-formylcytosine (5fC), a key epigenetic intermediate, enabling its detection in target DNA. The study demonstrates the potential of a DNA chip sensor with the probe in the detection of 5fC intermediate in biological samples, according to Phys.org.
The focus on cellular components continues to grow. According to Vox, there's a rising interest in mitochondria, the "powerhouse of the cell," as a key factor in wellness. Celebrities, tech professionals, and biohackers are increasingly focusing on mitochondria as a potential source of good health, rejuvenation, and longevity.
Discussion
AI Experts & Community
Be the first to comment